KCM

Knoll Capital Management Portfolio holdings

AUM $141M
This Quarter Return
+37.58%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$343M
AUM Growth
+$343M
Cap. Flow
+$79.5K
Cap. Flow %
0.02%
Top 10 Hldgs %
98.93%
Holding
21
New
7
Increased
3
Reduced
1
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MDVN
1
DELISTED
MEDIVATION, INC.
MDVN
$284M 82.63% 2,198,919 -45,600 -2% -$5.89M
AMPE
2
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$25.5M 7.43% 3,388,322
TOVX icon
3
Theriva Biologics
TOVX
$3.94M
$7.45M 2.17% 3,400,816
ARCT icon
4
Arcturus Therapeutics
ARCT
$462M
$6.28M 1.83% 1,115,315 +250,000 +29% +$1.41M
LUMO
5
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$5.6M 1.63% 102,437 +25,000 +32% +$1.37M
ADXS
6
DELISTED
Advaxis, Inc.
ADXS
$3.97M 1.16% 275,000 +50,000 +22% +$722K
KERX
7
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$2.55M 0.74% 200,000
ENLV icon
8
Enlivex Therapeutics
ENLV
$25M
$2.03M 0.59% 338,110
ALDX icon
9
Aldeyra Therapeutics
ALDX
$351M
$1.38M 0.4% +135,800 New +$1.38M
IOVA icon
10
Iovance Biotherapeutics
IOVA
$807M
$1.21M 0.35% +100,000 New +$1.21M
ADXSW
11
DELISTED
Advaxis, Inc. Warrants
ADXSW
$1.17M 0.34% 112,500
ABEO icon
12
Abeona Therapeutics
ABEO
$350M
$669K 0.19% +213,100 New +$669K
GLMD icon
13
Galmed Pharmaceuticals
GLMD
$6.96M
$612K 0.18% 65,000
NBSE
14
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$521K 0.15% +205,000 New +$521K
EVOK icon
15
Evoke Pharma
EVOK
$8.49M
$380K 0.11% +53,839 New +$380K
ZSAN
16
DELISTED
Zosano Pharma Corporation
ZSAN
$202K 0.06% +20,000 New +$202K
APTO
17
DELISTED
Aptose Biosciences, Inc.
APTO
$108K 0.03% +20,000 New +$108K
ASPX
18
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
-20,000 Closed -$1.05M
INO icon
19
Inovio Pharmaceuticals
INO
$126M
-82,088 Closed -$754K
PVCT
20
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
-200,000 Closed -$160K
NRX
21
DELISTED
NEPHROGENEX INC COM
NRX
-3,072 Closed -$41K